Hyphens Pharma International Ltd
SGX:1J5
Hyphens Pharma International Ltd
Accounts Receivables
Hyphens Pharma International Ltd
Accounts Receivables Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Accounts Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
H
|
Hyphens Pharma International Ltd
SGX:1J5
|
Accounts Receivables
S$45.2m
|
CAGR 3-Years
18%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
|
WAVE Life Sciences Ltd
NASDAQ:WVE
|
Accounts Receivables
$1.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-41%
|
CAGR 10-Years
N/A
|
|
|
Haw Par Corporation Ltd
SGX:H02
|
Accounts Receivables
S$47.8m
|
CAGR 3-Years
14%
|
CAGR 5-Years
10%
|
CAGR 10-Years
9%
|
|
|
I
|
IX Biopharma Ltd
SGX:42C
|
Accounts Receivables
S$2.1m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
19%
|
CAGR 10-Years
N/A
|
|
Hyphens Pharma International Ltd
Glance View
Hyphens Pharma International Ltd. is an investment holding company, which engages in the provision of specialty pharmaceutical and consumer healthcare products. The firm's principal activities are those of an investment holding company and provision of management services. The firm's segments include specialty pharma principals, proprietary brands, and medical hypermart and digital. The specialty pharma principals segment is engaged in the business of marketing and selling a range of specialty pharmaceutical products with exclusivity in the relevant ASEAN countries. The proprietary brands segment is engaged in the business of developing, marketing and selling its own proprietary range of dermatological products and health supplement products. The medical hypermart and digital segment is a wholesaler of pharmaceuticals and medical supplies in Singapore, which the Company and its subsidiaries position itself as a medical hypermart for healthcare professionals, healthcare institutions and retail pharmacies.
See Also
What is Hyphens Pharma International Ltd's Accounts Receivables?
Accounts Receivables
45.2m
SGD
Based on the financial report for Dec 31, 2024, Hyphens Pharma International Ltd's Accounts Receivables amounts to 45.2m SGD.
What is Hyphens Pharma International Ltd's Accounts Receivables growth rate?
Accounts Receivables CAGR 5Y
10%
Over the last year, the Accounts Receivables growth was 14%. The average annual Accounts Receivables growth rates for Hyphens Pharma International Ltd have been 18% over the past three years , 10% over the past five years .
You don't have any saved screeners yet